| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 2.733 | 7.856 | 9.310 | 8.142 |
| Total Income - EUR | - | - | - | - | - | - | 2.733 | 7.856 | 9.310 | 8.142 |
| Total Expenses - EUR | - | - | - | - | - | - | 4.186 | 7.089 | 7.080 | 8.217 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.453 | 768 | 2.230 | -75 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.535 | 532 | 1.873 | -75 |
| Employees | - | - | - | - | - | - | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Alergozone S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 117.443 | 115.754 | 111.503 | 109.266 |
| Current Assets | - | - | - | - | - | - | 557 | 1.420 | 589 | 3.839 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 134 | 11 | 0 | 674 |
| Cash | - | - | - | - | - | - | 423 | 1.409 | 589 | 3.165 |
| Shareholders Funds | - | - | - | - | - | - | -1.495 | -967 | 908 | 828 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 119.495 | 118.142 | 111.184 | 112.277 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7220 - 7220" | |||||||||
| CAEN Financial Year |
7220
|
|||||||||
Comments - Alergozone S.r.l.